Vivakor engages IME Capital to structure joint venture relationships for VIVASLICES MRI technology

Vivakor, Inc. (OTCBB:VIVK) announced today that the Company has engaged IME Capital to structure joint venture relationships for its VIVASLICES MRI technology. Vivakor Inc. has also engaged its board member John Gryga, former GE Healthcare Executive, to act as lead on all transactions for VIVASLICES. VIVASLICES is a software technology aimed at increasing image resolution of previous generations of MRI units, thereby saving hospitals and clinics with older equipment millions of dollars in costs related to purchasing new MRI units with enhanced image resolution capacity.

Vivakor's Chief Executive Officer and Chief Scientific Officer, Dr. Tannin Fuja, stated, "At this juncture we are pleased to seek joint venture relationships for VIVASLICES as the demand for cost effective healthcare solutions are necessary in the current economy. VIVASLICES' application for MRIs and CAT scans creates over $300 million annual market potential for the Company."